Doheny Asset Management /Ca Guardant Health, Inc. Transaction History

Doheny Asset Management /Ca

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$88.71 - $120.43 $141,936 - $192,688	-1,600 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$98.77 - $132.17 $113,585 - $151,995	-1,150 Reduced 41.82%	1,600 $200,000
Q2 2021 Aug 10, 2021	SELL	$109.77 - $165.68 $15,367 - $23,195	-140 Reduced 4.84%	2,750 $342,000
Q4 2020 Feb 26, 2021	BUY	$99.96 - $135.93 $288,884 - $392,837	2,890 New	2,890 $372,000
Q4 2019 Feb 11, 2020	SELL	$59.49 - $82.78 $461,047 - $641,545	-7,750 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$62.59 - $110.3 $485,072 - $854,825	7,750 New	7,750 $495,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

Stay updated on Doheny Asset Management /Ca with notifications on news.